We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+11.82%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$252M
AUM Growth
-$117M
Cap. Flow
-$138M
Cap. Flow %
-54.92%
Top 10 Hldgs %
67.87%
Holding
57
New
9
Increased
3
Reduced
13
Closed
18

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$23.6M
2
MMS icon
Maximus
MMS
+$13.9M
3
ANNX icon
Annexon
ANNX
+$8.5M
4
RLAY icon
Relay Therapeutics
RLAY
+$7.07M
5
IDYA icon
IDEAYA Biosciences
IDYA
+$4.66M

Top Sells

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$16.8M
2
LH icon
Labcorp
LH
+$16M
3
SNN icon
Smith & Nephew
SNN
+$14.4M
4
OGN icon
Organon & Co
OGN
+$12.6M
5
GSK icon
GSK
GSK
+$12M

Sector Composition

Rank Sector Weight
1 Healthcare 78.37%
2 Industrials 5.73%
3 Consumer Staples 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRLD icon
51
Prelude Therapeutics
PRLD
$362M
– –
-320,394
Closed -$1.22M
SNN icon
52
Smith & Nephew
SNN
$12.7B
– –
-579,619
Closed -$14.4M
SPRY icon
53
ARS Pharmaceuticals
SPRY
$532M
– –
-217,864
Closed -$1.85M
STOK icon
54
Stoke Therapeutics
STOK
$1.99B
– –
-175,301
Closed -$2.37M
THRD
55
DELISTED
Third Harmonic Bio
THRD
– –
-163,363
Closed -$2.12M
ZYME icon
56
Zymeworks
ZYME
$1.73B
– –
-491,128
Closed -$4.18M
ASLN
57
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
– –
-31,769
Closed -$76.2K
1 2
3

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Sio Capital Management held 57 positions worth $252M, down 32% from $370M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Sio Capital Management withdrew a net $138M in Q3 2024, closing 18 positions and reducing 13 holdings. Its most notable exit was Smith & Nephew, an estimated $14.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 69% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Sio Capital Management opened a new position in Teva Pharmaceuticals worth $24.3M.

  • Sio Capital Management's largest Q3 2024 buy was Teva Pharmaceuticals: 1,349,274 shares worth $24.3M.
  • Sio Capital Management added most to Compass Pathways in Q3 2024, an estimated $4.38M increase.
  • Sio Capital Management's biggest Q3 2024 reduction was Teleflex, cutting an estimated $16.8M.
  • Sio Capital Management fully exited Smith & Nephew in Q3 2024, selling an estimated $14.4M.
  • Sio Capital Management's ten largest holdings make up 68% of its $252M portfolio in Q3 2024.
  • Sio Capital Management opened 9 new positions and closed 18 in Q3 2024.
  • Sio Capital Management's portfolio value fell 32% quarter-over-quarter to $252M.

Based on Sio Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.